CN107007823B - Medicine for treating rhinitis and preparation method thereof - Google Patents

Medicine for treating rhinitis and preparation method thereof Download PDF

Info

Publication number
CN107007823B
CN107007823B CN201710422828.XA CN201710422828A CN107007823B CN 107007823 B CN107007823 B CN 107007823B CN 201710422828 A CN201710422828 A CN 201710422828A CN 107007823 B CN107007823 B CN 107007823B
Authority
CN
China
Prior art keywords
solution
nacl
medicine
collagen
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710422828.XA
Other languages
Chinese (zh)
Other versions
CN107007823A (en
Inventor
陈启瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Kangside Protein Engineering Co ltd
Original Assignee
Shenzhen Kangside Protein Engineering Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Kangside Protein Engineering Co ltd filed Critical Shenzhen Kangside Protein Engineering Co ltd
Publication of CN107007823A publication Critical patent/CN107007823A/en
Application granted granted Critical
Publication of CN107007823B publication Critical patent/CN107007823B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Abstract

A medicament for treating rhinitis and its preparation method, in the field of medicament, in order to provide a medicament that can completely cure rhinitis, the technical scheme of the invention is as follows: the invention relates to a medicine for treating rhinitis, which comprises NaCl and fish skin collagen, wherein the weight ratio of the NaCl to the fish skin collagen is 10:1, and the medicine has the beneficial effects that: 1. the raw materials of the medicine are easily available, are food-grade raw materials, have no irritation, and are safe and reliable; 2. the preparation process is simple and easy to prepare.

Description

Medicine for treating rhinitis and preparation method thereof
Technical Field
The invention belongs to the field of medicines, and particularly relates to a medicine for treating rhinitis and a preparation method thereof.
Background
Rhinitis is a common frequently-occurring disease, has no harm to life, can cause dizziness and discomfort of the whole body due to stuffy nose, stuffy nose and no dryness of nasal discharge, and seriously affects the work, study and life quality of people. According to the statistics of relevant departments, about 1 hundred million nasal diseases such as chronic rhinitis, allergic rhinitis, nasosinusitis and the like exist in the country, wherein the number of teenagers accounts for 6800 ten thousand, and the serious rhinitis can possibly cause nasopharyngeal carcinoma.
Various medicines for treating rhinitis on the market are called stranguria and enamel, but no medicines for killing nasal cavity bacteria and expanding micro-vessels exist, the medicines are used for one time, the medicines are stopped and recur, the patient feels no idea, and no rhinitis medicine for repairing nasal mucosa is found, so that the problem is solved.
Therefore, it is necessary to provide a medicine for radically treating rhinitis.
Disclosure of Invention
In order to solve the above mentioned problems, the invention provides a drug which can repair nasal mucosa and radically cure rhinitis, and in order to achieve the purpose, the technical scheme of the invention is as follows:
the inventor finds that only the fish skin collagen is not enough to achieve the curative effect, the effect of curing the rhinitis can be achieved only by simultaneously using the NaCl and the fish skin collagen in a ratio of 10:1, high-quality sodium chloride kills various harmful bacteria in the nasal cavity, including stubborn mildew, the fish skin collagen can repair damaged mucosa, the NaCl and the fish skin collagen interact with each other, and the rhinitis can be effectively and thoroughly cured.
Furthermore, the fish skin collagen is extracted from tilapia mossambica, and tilapia mossambica is an easily available food, safe and reliable, and has a wide source.
Furthermore, the molecular weight of the fish skin collagen is lower than 3000 daltons, the low molecular weight is more favorable for the absorption of the fish skin collagen, and the repairing effect is better.
Further, the Nacl is AR-grade Nacl.
The preparation method of the medicine for treating rhinitis is characterized by comprising the following steps:
(1) preparing a nasal mucosa repair factor, namely taking fresh tilapia skin, putting the skin into a flask, adding 0.01 mol/L hydrochloric acid solution, adding 1000ml hydrochloric acid solution into every 600g of the skin, heating and refluxing until the reaction solution is transparent colloid solution, removing a heat source, adding 0.05 mol/L NaoH solution to adjust the pH value to 4.8 +/-0.1 when the temperature of the solution is reduced to 43-48 ℃, so that the solution is turbid and flocculent precipitate exists, filtering, discarding filtrate, washing filter cakes with ionized water, and drying at 58-62 ℃ to obtain white-like colloid protein powder, namely the nasal mucosa repair factor;
(2) the preparation of the medicine comprises the steps of weighing NaCl and the nasal mucosa repair factor according to the weight ratio of 10:1, putting the Nacl and the nasal mucosa repair factor into a beaker, adding ionized water to prepare a solution containing 275 g/L g of NaCl and gelatin-derived protein powder, stirring the solution into a transparent solution, filtering the transparent solution by using a glass sand core, collecting filtrate, and sterilizing the filtrate to obtain the medicine.
The invention has the beneficial effects that: 1. the raw materials of the medicine are easily available, are food-grade raw materials, have no irritation, and are safe and reliable; 2. the preparation process is simple and easy to prepare.
Detailed Description
The present invention will be further described below.
Example 1
1. Preparation of the nasal mucosa repair factor:
taking 5000g of fresh tilapia, only taking fish skin to obtain about 600g of fish skin, placing the fish skin into a 2000M L three-neck flask, adding 1000M L0.01.01 mol/L hydrochloric acid solution, heating, refluxing for 6 hours to enable reaction liquid to be transparent colloid liquid, stopping heating, cooling the liquid to about 45 ℃, slowly adding 0.05 mol/L NaoH solution, adjusting the pH value to 4.8 +/-0.1 to enable the solution to be turbid and have floccule precipitate, filtering, discarding filtrate, adding a small amount of ionized water for spray washing filter cakes, pumping to obtain wet matters, drying the wet matters at 60 ℃, obtaining about 100g of white colloid source protein powder, and obtaining the nasal mucosa repair factor.
2. Weighing 250g of NaCl and 25g of nasal mucosa repair factor accurately according to the prescription, adding into a 2000ml wide-mouth beaker, adding ionized water, fully stirring to obtain 1000ml of transparent solution, filtering with a No. 3 glass sand core, collecting filtrate, filling the filtrate into a 15ml glass bottle, and sterilizing at 100 ℃ for 20 minutes to obtain the medicine for treating rhinitis.
Example 2
1. Preparation of the nasal mucosa repair factor:
taking 5000g of fresh tilapia, only taking fish skin, obtaining about 600g of fish skin, placing the fish skin into a 2000M L three-neck flask, adding 1000M L0.01.01 mol/L hydrochloric acid solution, heating, refluxing for 7 hours to enable reaction liquid to be transparent colloid liquid, stopping heating, cooling the liquid to about 46 ℃, slowly adding 0.05 mol/L NaoH solution, adjusting the pH value to 4.8 +/-0.1 to enable the solution to be turbid and have floccule precipitate, filtering, discarding filtrate, adding a small amount of ionized water for washing a filter cake, pumping to obtain wet matter, drying the wet matter at 58-62 ℃ to obtain about 100g of white collagen powder, namely the nasal mucosa repair factor.
2. Weighing 250g of NaCl and 25g of nasal mucosa repair factor accurately according to the prescription, adding into a 2000ml wide-mouth beaker, adding ionized water, fully stirring to obtain 1000ml of transparent solution, filtering with a No. 3 glass sand core, collecting filtrate, filling the filtrate into a 15-20ml glass bottle, and sterilizing at 100 ℃ for 20 minutes to obtain the product.
Example 3
The raw materials used by the invention are all prepared from common food, and are prepared into an externally-used 'Bikangling' medicine, and the medicine is smeared on the skin of mice and rabbits without any abnormal expression, which indicates that the product is free from allergy and stimulation.
The product can be directly used by human body without toxicity and side effect, and has satisfactory effect. Starting from month 9 2012 to month 2 2017, a statistic of about 350 patients with various rhinitis patients for various age groups is compiled as follows:
nose health-care summary table for trial use
Figure 347592DEST_PATH_IMAGE002
The medicine prepared by the application has the best treatment effect on the rhinitis of children, and is an excellent medicine for treating the rhinitis of children with more strict medication because the raw materials of the medicine are edible.
Example 4
The patients male, 8 years old and 4 years old, find that the rhinitis is infected, various rhinitis drugs are used, the symptoms are improved when the drug is used, and the symptoms reappear in two days after the drug is stopped. Then, a little liquid medicine is dipped in the Bikangling solution prepared by the method of the application and a cotton ball of absorbent medicine, and is plugged into nostrils, for convenience of ventilation, the two sides are plugged in turns for 3-5 times per day, symptoms are basically eliminated by only two days, the nasal Kangling solution is continuously used for two days, the nasal Kangling solution is cured, and the nasal Kangling solution has no recurrence for more than 4 years.
When a certain person in yellow is a male, the person is 43 years old, the person complains about rhinitis for nearly 20 years, various medicines are used, symptoms are improved when the medicine is used, but the symptoms appear in three days, the symptoms disappear after the medicine prepared by the application is used for later trial for three days, and the symptoms are more than two years till now, and the symptoms do not relapse.
A certain old man, 45 years old, complain of the disease for at least 20 years, cannot take effect after using various rhinitis medicines, a patient has no any confidence in the disease condition, the variety is introduced by a commenting on the deep office in the west and the river, the mood of trying one test is held, the first day is used, the nose is passed, the nasal discharge is not flowed, the joy is extremely high, the nasal discharge is continuously used for 7 days, and the patient is comprehensively recovered.
When a certain woman is aged for 81 years, the patient self-complains of nasosinusitis, the condition of the patient is over 30 years, the patient has nasal obstruction, rhinorrhoea and dizziness, and countless medicines are used, so that the problems cannot be solved, the symptoms are eliminated after the product is used for 10 days, but the symptoms are generated after more than ten days, and the medicine liquid is continuously used for 7 days, so that eight months exist till now, and no symptoms are generated. On happy land, thank you for the old and stubborn disease that she has been for more than thirty years. It can be seen that the shorter the age, the shorter the period of cure and the better the therapeutic effect.

Claims (3)

1. A preparation method of a medicine for treating rhinitis is characterized in that the medicine comprises NaCl and fish skin collagen, the weight ratio of the NaCl to the fish skin collagen is 10:1, and the fish skin collagen is extracted from tilapia;
the preparation method comprises the following steps:
(1) preparing a nasal mucosa repair factor, namely taking fresh tilapia skin, putting the skin into a flask, adding 0.01 mol/L hydrochloric acid solution, covering the skin, heating and refluxing until the reaction solution is transparent colloid solution, removing a heat source, adding 0.05 mol/L NaOH solution to adjust the pH value to 4.8 +/-0.1 when the temperature of the solution is reduced to 43-48 ℃, enabling the solution to be turbid and have flocculent precipitates, filtering, discarding filtrate, adding ionized water for washing, and drying at 58-62 ℃ to obtain white-like collagen powder;
(2) the preparation of the medicine comprises the steps of weighing NaCl and collagen powder according to the weight ratio of 10:1, putting the NaCl and collagen powder into a beaker, adding ionized water to prepare a solution containing NaCl and gelatin-derived protein powder 275 g/L, stirring the solution into a transparent solution, filtering the transparent solution by using a glass sand core, collecting filtrate, and sterilizing the filtrate to obtain the medicine.
2. The process for preparing a medicament as claimed in claim 1, wherein the fish skin collagen has a molecular weight of less than 3000 daltons.
3. The method of claim 1, wherein the NaCl is AR grade NaCl.
CN201710422828.XA 2017-03-21 2017-06-07 Medicine for treating rhinitis and preparation method thereof Active CN107007823B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710168316 2017-03-21
CN2017101683165 2017-03-21

Publications (2)

Publication Number Publication Date
CN107007823A CN107007823A (en) 2017-08-04
CN107007823B true CN107007823B (en) 2020-07-14

Family

ID=59451060

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710422828.XA Active CN107007823B (en) 2017-03-21 2017-06-07 Medicine for treating rhinitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107007823B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114452247A (en) * 2022-03-11 2022-05-10 包头瑞象控股中心(有限合伙) Rare earth washing liquor for rhinitis and preparation method thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010082138A2 (en) * 2009-01-16 2010-07-22 Geistlich Pharma Ag Method and membrane for tissue regeneration
CN103989828A (en) * 2014-05-21 2014-08-20 海南生态美生物科技有限公司 Composition for promoting wound healing and preparation method thereof
CN104292305A (en) * 2014-01-17 2015-01-21 河南科技大学 Polypeptide, preparation method and application thereof
CN104940994A (en) * 2015-07-14 2015-09-30 江苏威克斯医疗科技有限公司 Artificial nasal mucosa and application thereof
CN105709267A (en) * 2015-12-04 2016-06-29 陕西巨子生物技术有限公司 Mucosa-repairing gel containing human-like collagen
CN106491714A (en) * 2016-11-10 2017-03-15 济宁沭康生物科技有限公司 A kind of child's collunarium antibacterial liquid
CN106491518A (en) * 2016-11-25 2017-03-15 陕西巨子生物技术有限公司 A kind of Human-like Collagen gynecological cell migration gel
CN106492267A (en) * 2016-11-25 2017-03-15 陕西巨子生物技术有限公司 A kind of Human-like Collagen anorectal Mucous rehabilitation gel
CN106540314A (en) * 2016-11-25 2017-03-29 陕西巨子生物技术有限公司 A kind of Human-like Collagen nasal membrane repairs gel

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010082138A2 (en) * 2009-01-16 2010-07-22 Geistlich Pharma Ag Method and membrane for tissue regeneration
CN104292305A (en) * 2014-01-17 2015-01-21 河南科技大学 Polypeptide, preparation method and application thereof
CN103989828A (en) * 2014-05-21 2014-08-20 海南生态美生物科技有限公司 Composition for promoting wound healing and preparation method thereof
CN104940994A (en) * 2015-07-14 2015-09-30 江苏威克斯医疗科技有限公司 Artificial nasal mucosa and application thereof
CN105709267A (en) * 2015-12-04 2016-06-29 陕西巨子生物技术有限公司 Mucosa-repairing gel containing human-like collagen
CN106491714A (en) * 2016-11-10 2017-03-15 济宁沭康生物科技有限公司 A kind of child's collunarium antibacterial liquid
CN106491518A (en) * 2016-11-25 2017-03-15 陕西巨子生物技术有限公司 A kind of Human-like Collagen gynecological cell migration gel
CN106492267A (en) * 2016-11-25 2017-03-15 陕西巨子生物技术有限公司 A kind of Human-like Collagen anorectal Mucous rehabilitation gel
CN106540314A (en) * 2016-11-25 2017-03-29 陕西巨子生物技术有限公司 A kind of Human-like Collagen nasal membrane repairs gel

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Remodelling of nasal mucosa in mild and severe persistent allergic rhinitis with special reference to the distribution of collagen, proteoglycans, and lymphatic vessels;T. H. Kim等;《Clinical & Experimental Allergy》;20101231;第40卷;第1742-1754页 *
浅谈鱼皮胶原蛋白的利用;傅燕凤等;《食品研究与开发》;20040430;第25卷(第2期);第16-18页 *
鱼皮胶原蛋白研究进展;吴丹等;《应用研究》;20071231(第6期);第23-25页 *
鼻内镜鼻窦开放后两种鼻腔填塞材料效果的比较;谷李欣等;《实用医学杂志》;20121231;第28卷(第24期);第4102-4104页 *

Also Published As

Publication number Publication date
CN107007823A (en) 2017-08-04

Similar Documents

Publication Publication Date Title
CN103860625A (en) Cranberry extract eye ophthalmic preparation and preparation method and uses thereof
CN107007823B (en) Medicine for treating rhinitis and preparation method thereof
CN105362295A (en) Periplaneta americana pharmaceutical composition for treating acute and chronic faucitis and dental ulcers and preparation method thereof
CN103977194A (en) Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot
CN105012487B (en) Children's nose, which relaxes, leads to nasal drops
CN107496525B (en) Traditional Chinese medicine composition for treating cancer pain diseases and application thereof
CN104758348B (en) A kind of Chinese medicine composition preparation is used for the purposes of tumor chemoradiotherapy related oral ulcer
CN103751499B (en) A kind of Chinese medicine composition treating oral ulcer
CN102114116B (en) Traditional Chinese medicine for treating esophageal carcinoma
CN104983812B (en) A kind of composition for treating ultraviolet light allergy and preparation method thereof
CN102727834B (en) Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof
CN112057561B (en) Traditional Chinese medicine nasal spray for treating allergic rhinitis
CN105396041A (en) Traditional Chinese medicine composition for treating stomach cold and preparation method thereof
CN102614252B (en) Prescription for treating cataract
CN1234404C (en) Medicine for preventing and treating chronic exhaustion syndrome and preparing method thereof
CN105168444B (en) One kind is for preventing and treating livestock and poultry respiratory syndrome drug
WO2022126255A1 (en) Antioxidant nutritional supplement for immune system support
CN105434678A (en) Composition for preventing and/or treating sub-health caused by using of electronic products
CN111067938A (en) Traditional Chinese medicine formula for treating rhinitis and preparation method thereof
CN108403991A (en) Pill of Eight Treasures treats the purposes of face acnes and its pharmaceutical composition of pill of Eight Treasures
CN109999116A (en) A kind of liniment and preparation method thereof for treating cat fever
CN107812099A (en) A kind of Chinese medicine for being used to treat chloasma
CN112823803A (en) Soft capsule for detumescence and removing toxicity and preparation process thereof
CN107913360A (en) A kind of Chinese and Western medicine compound preparation for treating intracranial tumors and preparation method
CN107260903A (en) A kind of composition for slowing down chemotherapeutics side effect

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant